Sarki A. Abdulkadir
- Molecular Biology top 2%
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 2%
- Pathology and Forensic Medicine top 2%
- Co-authors
- Jeffrey MilbrandtMeejeon RohJongchan KimRiet van der MeerDavid GiusJeffrey A. MageePeter A. HumphreyVinay Sagar
- Topics
- Prostate Cancer Treatment and Research (34 papers)Cancer Mechanisms and Therapy (12 papers)Ubiquitin and proteasome pathways (9 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesIndiaPhilippines
In The Last Decade
Sarki A. Abdulkadir
87 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Molecular Biology 2.6k
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 998
- Cancer Research 881
- Pathology and Forensic Medicine 518
Countries citing papers authored by Sarki A. Abdulkadir
This map shows the geographic impact of Sarki A. Abdulkadir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarki A. Abdulkadir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarki A. Abdulkadir more than expected).
Fields of papers citing papers by Sarki A. Abdulkadir
This network shows the impact of papers produced by Sarki A. Abdulkadir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarki A. Abdulkadir. The network helps show where Sarki A. Abdulkadir may publish in the future.
Co-authorship network of co-authors of Sarki A. Abdulkadir
This figure shows the co-authorship network connecting the top 25 collaborators of Sarki A. Abdulkadir. A scholar is included among the top collaborators of Sarki A. Abdulkadir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarki A. Abdulkadir. Sarki A. Abdulkadir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 9 | |
| 5 | 13 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 37 | |
| 11 | 24 | |
| 12 | 46 | |
| 13 | 14 | |
| 14 | 41 | |
| 15 | 58 | |
| 16 | 34 | |
| 17 | 17 | |
| 18 | 101 | |
| 19 | EGR1 promotes androgen-independent growth and prothrombotic state in prostate cancer | 1 |
| 20 | 178 |
About Sarki A. Abdulkadir
Sarki A. Abdulkadir is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 93 papers that have together received 4.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (34 papers), Cancer Mechanisms and Therapy (12 papers) and Ubiquitin and proteasome pathways (9 papers). The work is most often cited by research in Geriatrics and Gerontology (447 citations), Cancer Research (881 citations) and Oncology (1.2k citations). Sarki A. Abdulkadir has collaborated with scholars based in United States, India and Philippines. Frequent co-authors include Jeffrey Milbrandt, Meejeon Roh, Jongchan Kim, Riet van der Meer, David Gius, Jeffrey A. Magee, Peter A. Humphrey, Vinay Sagar, William J. Catàlona and C.K. Naughton. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.